JW (Cayman) Therapeutics Co. Ltd. (HK:2126) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
JW (Cayman) Therapeutics Co. Ltd. successfully conducted its Annual General Meeting on June 18, 2024, where all resolutions, including the adoption of financial statements and re-election of directors, were overwhelmingly passed by shareholders. Notably, the re-appointment of PricewaterhouseCoopers as the company auditor and the authorization for the board to issue additional shares up to 20% of the total issued shares received near-unanimous support.
For further insights into HK:2126 stock, check out TipRanks’ Stock Analysis page.
